Segment Information and Concentrations:

9 Months Ended

Mar. 31, 2012

Notes to Financial Statements

Segment Information and Concentrations:

4. Segment Information and Concentrations:

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (ABenchtop Laboratory Equipment), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (ACatalyst Research Instruments) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors (“Bioprocessing Systems”).

 Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended March 31, 2012
Net Sales	$	1,025,300	$	418,300		$	75,900		$	—		$	1,519,500
Foreign Sales		613,900		405,900			3,600			—			1,023,400
Profit (Loss)		85,000		(76,000	)		(16,300	)		(4,100	)		(11,400	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		7,500		—			—			—			7,500
Depreciation and Amortization		12,500		5,900			24,000			—			42,400
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended March 31, 2011
Net Sales	$	1,164,900	$	295,400		$	—		$	—		$	1,460,300
Foreign Sales		720,800		201,400			—			—			922,200
Profit (Loss)		138,900		(74,200	)		—			9,800			74,500
Assets		2,313,900		1,300,400			—			1,318,400			4,932,700
Long-Lived Asset Expenditures		5,800		800			—			—			6,600
Depreciation and Amortization		13,800		32,800			—			—			46,600

Approximately 62% and 70% of net sales of benchtop laboratory equipment for the three month periods ended March 31, 2012 and 2011, respectively, were derived from the Company=s main product, the Vortex-Genie 2 mixer, excluding accessories.

Two benchtop laboratory equipment customers accounted for approximately 27% and 23% of the segment=s net sales,(42% and 19% of total net sales) for the three month periods ended March 31, 2012 and 2011, respectively.

Sales of catalyst research instruments are generally pursuant to large orders averaging more than $100,000 per order to a limited numbers of customers. Sales to two customers in the three months ended March 31, 2012 and two different customers in the three months ended March 31, 2011, accounted respectively for 92% and 93% of the segment=s net sales (25% and 19% of total net sales) for the respective periods.

Nine months ended March 31, 2012
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Net Sales	$	3,208,900	$	973,200		$	75,900		$	—		$	4,258,000
Foreign Sales		1,977,700		527,000			3,600			—			2,508,300
Profit (Loss)		357,400		(252,400	)		(48,600	)		(62,300	)		(5,900	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		21,500		49,500			876,000			—			947,000
Depreciation and Amortization		36,700		68,900			36,000			—			141,600
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Nine months ended March 31, 2011
Net Sales	$	3,431,900	$	1,315,300		$	—		$	—		$	4,747,200
Foreign Sales		1,946,300		746,000			—			—			2,692,300
Profit (Loss)		486,800		(161,900	)		—			25,400			350,300
Assets		2,313,900		1,300,400			—			1,318,400			4,932,700
Long-Lived Asset Expenditures		38,100		23,400			—			—			61,500
Depreciation and Amortization		42,600		99,600			—			—			142,200

Approximately 63% and 69% of net sales of benchtop laboratory equipment for the nine month periods ended March 31, 2012 and 2011, respectively, were derived from the Company=s main product, the Vortex-Genie 2 mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted for approximately 26% and 29% of the segment=s net sales (20% and 21% of total net sales) for the nine month periods ended March 31, 2012 and 2011, respectively.

Sales of catalyst research instruments to three customers in the nine months ended March 31, 2012 and to three other customers in the nine months ended March 31, 2011 accounted for approximately 65% and 43% of that segment's net sales (15% and 12% of total net sales) for the respective nine month periods.

The Company’s foreign sales are principally made to customers in Europe and Asia.